KM Corporation (KOSDAQ:083550)
South Korea · Delayed Price · Currency is KRW 3,685.00
-25.00 (-0.67%)
At close: Apr 3, 2026
KM Corporation Revenue
In the year 2025, KM Corporation had annual revenue of 135.41B KRW with 3.26% growth. KM Corporation had revenue of 36.17B in the quarter ending December 31, 2025, with 6.98% growth.
Revenue
135.41B
Revenue Growth
+3.26%
P/S Ratio
0.35
Revenue / Employee
533.13M
Employees
254
Market Cap
47.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 135.41B | 4.27B | 3.26% |
| Dec 31, 2024 | 131.14B | 3.36B | 2.63% |
| Dec 31, 2023 | 127.78B | -23.87B | -15.74% |
| Dec 31, 2022 | 151.65B | 8.40B | 5.87% |
| Dec 31, 2021 | 143.25B | -44.67B | -23.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JW Shinyak | 81.04B |
| Sewoon Medical | 63.66B |
| CG MedTech | 47.23B |
| OSTEONIC | 45.39B |
| Wonbiogen | 35.24B |
| Billions | 25.31B |
| SCL Science | 22.01B |
| MEDYSSEY Co.,Ltd | 10.60B |